Skip to search formSkip to main contentSkip to account menu

Mestinon

Known as: Mestinon Bromide 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (2)

PyridostigminePyridostigmine Bromide
Pyridostigmine Bromide 12 MG/ML Oral Solution [Mestinon]Pyridostigmine Bromide 180 MG Extended Release Oral Tablet [Mestinon]Pyridostigmine Bromide 60 MG Oral Tablet [Mestinon]Pyridostigmine Oral Tablet [Mestinon]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Evaluation of hypermethylation and expression pattern of glutamate and dopamine receptors genes in patients with schizophrenia
© The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https… 
2013
2013
Preparation of mestinon-phospholipid complex and its promoting effect on intestinal absorption in rats
Objective To study the role of mestinon-phospholipid complex in promoting the intestinal absorption of mestinon in rats.Methods… 
1986
1986
[Acetylcholine receptor antibody in D-penicillamine therapy].
Since 1978 a 63-year-old woman with rheumatoid arthritis received D-penicillamine (D-PA) in a daily dose of 250-500 mg (mean 300… 
1970
1970
Pharmacodynamic effects of mestinon (dimethyl-carbamic acid ester of 3-hydroxy-1-methyl-pyridinum bromide).
1967
1967
Pyridostigmin (mestinon) as an antagonist of d-tubocurarine.
The effects of pyridostigmin were compared with those of edrophonium and neostigmine in anesthetized patients. Pyridostigmin was… 
1957
1957
Treatment of myasthenia gravis; prolonged action with multiple-dose tablets of neostigmine bromide and mestinon bromide.
The anticholinesterase drugs used in treating myasthenia gravis do not have a prolonged action. The ordinary dosage forms must be… 
1955
1955
Advantages of pyridostigmine bromide (mestinon) and edrophonium chloride (tensilon) in the treatment of transitory myasthenia gravis in the neonatal period.
THIS paper emphasizes the value of recognizing the symptoms of myasthenia gravis, so that appropriate treatment may be given to… 
1955
1955
Treatment of myasthenia gravis with pyridostigmine (mestinon)
1955
1955
Initial experiments with pyridostigmine (mestinon Roche)
1955
1955
[Clinical observations on the potentiation of dromoran Roche with mestinon].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)